Canopy Growth Corporation (CGC)

NASDAQ • Healthcare

$0.82

-$0.01 (-2.3%)

Market closed

October 9, 2026 at 20:00 UTC

Open$0.86

Day Range$0.82 - $0.86

Avg. Volume (3M)2.1M

Market Cap$349.1M

52 Week Range

$0.81$2.38

Next EarningsIn 27 daysNov 6, 2026

12H

All

07:33:06 UTC

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$81.1M100%

Gross Profitminus cost of goods$22.2M27%

In plain terms: out of every $100 in revenue, Canopy Growth Corporation currently loses $18.

Fundamentals & Financials

Revenue (TTM)

$321.3M

Net Income (TTM)

-$259.2M

EPS (TTM)

-$0.69

ROA (TTM)

-21.43%

Current Ratio

3.04

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+4.7%Q3 2025-$0.22

+93.6%Q4 2025-$0.01

-507.7%Q1 2026-$0.25

-379.3%Q2 2026-$0.29

+50.0%Q3 2026-$0.02

Nov 6

in 27 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Beat +50.0%

Canopy Growth beat revenue expectations in the first fiscal quarter of 2027, as revenue rose about 98% year over year to about CAD 142.6 million from about CAD 72.1 million a year earlier and topped the roughly CAD 58.2 million estimate by about 145% when it reported on Aug. 7, 2026. Gross margin held near 22%, while operating margin was roughly -16% and operating loss came to about CAD 22.1 million. Net income was a loss of about CAD 20.7 million, up 50% year over year from a loss of about CAD 41.5 million a year earlier, and operating cash flow was negative CAD 35.5 million.

Next report — what to expect

Canopy Growth Corporation (CGC) reports next on November 6, 2026. The consensus calls for EPS of -CAD 0.03 on revenue of CAD 57.7 million. As trailing context, revenue grew +12.5% year over year last quarter. CGC has beaten EPS in 3 of 8 most recent quarters.

View full earnings history

About Canopy Growth Corporation

Canopy Growth Corporation (NASDAQ: CGC) specializes in the cultivation, marketing, and retail sale of cannabis and hemp-derived products through retail channels, operating in healthcare as a specialty drug manufacturer and consumer cannabis company. In FY2025, revenue was CAD 483.7 million. The company went public in 2014 and was formerly known as Tweed Marijuana Inc.

Name

Canopy Growth Corporation

CEO

Luc Mongeau

Website

www.canopygrowth.com

Industry

Healthcare

Year Founded

2009

Employees

1,128

Today's Snapshot

AI-generated

The day ended with CGC 2.3% lower at 0.83, against a firmer sector. At the close, CGC was within 2.1% of its 52-week low of 0.81.

Trading Volume

Above 10d avg 2.3M

2.3M

vs S&P 500 Today

Underperforming Market

-2.92%

Updated: October 9, 2026 at 20:20 UTC

Technical Indicators

2 Buy0 Neutral6 Sell

CGC is showing a clear bearish structure with price trading below short-, medium- and 200-day moving averages, reinforcing a longer-term downtrend while ADX around the mid-20s indicates a modestly persistent trend. Momentum is mixed: RSI is deeply oversold but CCI and MACD remain negative, suggesting selling pressure continues despite oversold readings. Volatility is moderate with ATR near four percent of the price, and on-balance volume is strongly negative, signaling distribution. The classic pivot sits slightly above the market and is holding. Technical takeaway: Strong Sell — trend and volume favour the bearish case despite oversold momentum.

All signals